|
Volumn 16, Issue 4, 2002, Pages 531-536
|
Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma
a a a a a |
Author keywords
CD16 56; CD19; CD4; CD8; Chemotherapy; HIV viral load; Lymphoma
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTINEOPLASTIC AGENT;
ANTIRETROVIRUS AGENT;
BLEOMYCIN;
CD16 ANTIGEN;
CD19 ANTIGEN;
CD4 ANTIGEN;
CD56 ANTIGEN;
CD8 ANTIGEN;
CYCLOPHOSPHAMIDE;
DACARBAZINE;
DOXORUBICIN;
ETOPOSIDE;
METHOTREXATE;
PREDNISOLONE;
VINBLASTINE;
VINCRISTINE;
VIRUS RNA;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADULT;
AIDS RELATED COMPLEX;
ANTIBIOTIC PROPHYLAXIS;
ARTICLE;
B LYMPHOCYTE;
CYTOTOXIC T LYMPHOCYTE;
FEMALE;
HELPER CELL;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN CELL;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOCOMPETENT CELL;
LYMPHOCYTE COUNT;
LYMPHOMA;
MAJOR CLINICAL STUDY;
MALE;
NATURAL KILLER CELL;
OPPORTUNISTIC INFECTION;
PRIORITY JOURNAL;
T LYMPHOCYTE SUBPOPULATION;
VIRUS LOAD;
ADULT;
ANTI-HIV AGENTS;
ANTIGENS, CD56;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
B-LYMPHOCYTES;
BIOLOGICAL MARKERS;
CD4 LYMPHOCYTE COUNT;
CD8-POSITIVE T-LYMPHOCYTES;
FEMALE;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HIV-1;
HUMANS;
KILLER CELLS, NATURAL;
LYMPHOCYTE COUNT;
LYMPHOMA, AIDS-RELATED;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
RECEPTORS, IGG;
REVERSE TRANSCRIPTASE INHIBITORS;
VIRAL LOAD;
|
EID: 0037040371
PISSN: 02699370
EISSN: None
Source Type: Journal
DOI: 10.1097/00002030-200203080-00003 Document Type: Article |
Times cited : (87)
|
References (20)
|